Received Sep 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | LA |
Injection site pain; This is a spontaneous report received from a Consumer or other non HCP. A 53-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 12Sep2025 at 16:00 as dose 1, single (Batch/Lot number: unknown) at the age of 53 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing); "Allergy: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 12Sep2025 at 16:00, outcome "recovering", described as "Injection site pain". Therapeutic measures were not taken as a result of vaccination site pain. Additional information: Patient didn't received any other vaccines on the same date as the vaccine. Patient didn't received any other vaccines within 4 weeks prior to the vaccine. Patient took other medications within 2 weeks of the event started. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Blood pressure high; Hyperlipidemia; Penicillin allergy
ATORVASTATIN